No Data
No Data
Express News | China National Medical Products Administration Has Approved Marinus Pharmaceuticals' Ganaxolone Oral Suspension For Epileptic Seizures In Patients Two Years Of Age And Older With CDKL5 Deficiency Disorder
Express News | Marinus Pharmaceuticals- in Marigold Trial, Ganaxolone Was Generally Well-Tolerated & Showed Safety Profile Consistent With Previous Clinical Trials
Express News | Marinus Pharmaceuticals Announces Ganaxolone Approved in China as First Treatment for Seizures Associated With Cdkl5 Deficiency Disorder
Ladenburg Thalmann Maintains Marinus Pharmaceuticals(MRNS.US) With Buy Rating, Maintains Target Price $4
Ladenburg Thalmann analyst Michael Higgins maintains $Marinus Pharmaceuticals(MRNS.US)$ with a buy rating, and maintains the target price at $4.According to TipRanks data, the analyst has a success ra
Truist Financial Maintains Marinus Pharmaceuticals(MRNS.US) With Buy Rating
Truist Financial analyst Joon Lee maintains $Marinus Pharmaceuticals(MRNS.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 48.3% and a total average return of 23.0%
Express News | Truist Securities Maintains Buy on Marinus Pharma, Maintains $10 Price Target